Asthma: 2015 and beyond

Respir Care. 2011 Sep;56(9):1389-407; discussion 1407-10. doi: 10.4187/respcare.01334.

Abstract

Asthma is a multifactorial, chronic inflammatory disease of the airways. The knowledge that asthma is an inflammatory disorder has become a core fundamental in the definition of asthma. Asthma's chief features include a variable degree of air-flow obstruction and bronchial hyper-responsiveness, in addition to the underlying chronic airways inflammation. This underlying chronic airway inflammation substantially contributes to airway hyper-responsiveness, air-flow limitation, respiratory symptoms, and disease chronicity. However, this underlying chronic airway inflammation has implications for the diagnosis, management, and potential prevention of the disease. This review for the respiratory therapy community summarizes these developments as well as providing an update on asthma epidemiology, natural history, cause, and pathogenesis. This paper also provides an overview on appropriate diagnostic and monitoring strategies for asthma, pharmacology, and newer therapies for the future as well as relevant management of acute and ambulatory asthma, and a brief review of educational approaches.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenergic beta-2 Receptor Agonists / therapeutic use
  • Ambulatory Care
  • Asthma / diagnosis*
  • Asthma / drug therapy
  • Asthma / epidemiology
  • Asthma / physiopathology
  • Asthma / therapy*
  • Breath Tests
  • Bronchodilator Agents / therapeutic use
  • Drug Delivery Systems
  • Emergency Medical Services
  • Humans
  • Hygiene
  • Ipratropium / therapeutic use
  • Leukotriene Antagonists / therapeutic use
  • Self Care
  • Socioeconomic Factors

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-2 Receptor Agonists
  • Bronchodilator Agents
  • Leukotriene Antagonists
  • Ipratropium